Helene Laude | Malnutrition | Best Researcher Award

Dr. Helene Laude | Malnutrition | Best Researcher Award

Institute Pasteur | France

Dr. Helene Laude, MD, PhD, is a distinguished French physician-scientist recognized for her expertise in virology, immunology, and infectious diseases. Currently affiliated with the Institute Pasteur, she has made significant contributions to understanding viral pathogenesis, host immunity, and infection-related carcinogenesis. Her research has advanced knowledge on viruses such as SARS-CoV-2, Monkeypox, Zika, and various oncogenic viruses including Merkel polyomavirus and cytomegalovirus. Dr. Helene Laude has served as principal investigator for major clinical and immunological studies, focusing on mucosal immunity, biomarker discovery, and population-based cohort investigations. With 998 citations by 853 documents, 32 publications, and an h-index of 15, her scholarly impact underscores her leadership in translational virology and public health research. Her publications in The Lancet Oncology, Scientific Reports, Frontiers in Immunology, and Cell Host & Microbe highlight her dedication to advancing biomedical science. A respected expert and reviewer for leading organizations such as ANRS, INCa, and IARC, she contributes to global evaluations on viral carcinogenicity and diagnostic innovation. Beyond research, Dr. Helene Laude is actively involved in academic teaching at renowned institutions including the Institute Pasteur, Sorbonne University, and Paris Descartes University, mentoring future scientists and medical professionals in vaccinology, virology, and cancer immunology. Her achievements exemplify excellence in clinical investigation and molecular medicine, bridging laboratory discoveries with human health applications to enhance global infectious disease preparedness and cancer prevention.

Profiles: Scopusย 

Featured Publications

Karagas, M. R., Kaldor, J., Michaelis, M., Muchengeti, M. M., Alfaiate, D., Argirion, I., Chen, X., Cunha, C., Hantz, S., Koljonen, V., Laude, H. C., Lui, W. O., Nevels, M. M., O’Brien, T. R., Scheurer, M. E., Touze, A., Wiemels, J. L., Benbrahim-Tallaa, L., de Conti, A., Facchin, C., Madia, F., Pasqual, E., Wedekind, R., Aguilera-Buenosvinos, I., Clifford, G., Deng, X., Dongoran, R. A., Ezzemni, S., Huang, Y., Suonio, E., Zhai, Y., Mattock, H., Schubauer-Berigan, M. K., & Kunzmann, A. T. (2025). Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirus. Lancet Oncology, S1470-2045(25)00403-6.

Beeker, L., Obadia, T., Bloch, E., Garcia, L., Le Fol, M., Charmet, T., Arowas, L., Artus, R., Cheny, O., Cheval, D., Dahoumane, Y., Delhaye, M., Ergen, D., Essaidani, M., Fanaud, C., Fernandes Pellerin, S., Jolly, N., Laude, H., Roux, E., Samson, M., Sangari, L., Ungeheuer, M. N., Vacant, S., Zayoud, A., Donnadieu, F., Pelleau, S., Galmiche, S., Fontanet, A., & White, M. (2025). Correlates of protection against symptomatic COVID-19: The CORSER 5 case-control study. Open Forum Infectious Diseases, 12(1).

Combes, J. D., Didelot, J. M., Radenne, S., Zaegel-Faucher, O., Lesage, A. C., Siproudhis, L., Piroth, L., Marchand, L., Heard, I., Hoyeau, N., Henno, S., Darragh, T. M., Alberts, C. J., Clifford, G. M., & Etienney, I.; ANRS-EP57-APACHES Study group. (2024). Cumulative detection of anal high-grade squamous intraepithelial lesions over 2-year follow-up in men who have sex with men living with human immunodeficiency virus in France. Journal of Infectious Diseases, 230(1).

Martinez, F. J., Guillotte-Blisnick, M., Huon, C., England, P., Popovici, J., Laude, H., Arowas, L., Ungeheuer, M. N., Reimer, J. M., Carter, D., Reed, S., Mukherjee, P., Chauhan, V. S., & Chitnis, C. E. (2023). Immunogenicity of a Plasmodium vivax vaccine based on the Duffy binding protein formulated using adjuvants compatible for use in humans. Scientific Reports, 13(1), 13904.

Cuche, C., Mastrogiovanni, M., Juzans, M., Laude, H., Ungeheuer, M. N., Krentzel, D., Gariboldi, M. I., Scott-Algara, D., Madec, M., Goyard, S., Floch, C., Chauveau-Le Friec, G., Lafaye, P., Renaudat, C., Le Bidan, M., Micallef, C., Schmutz, S., Mella, S., Novault, S., Hasan, M., Duffy, D., Di Bartolo, V., & Alcover, A. (2023). T cell migration and effector function differences in familial adenomatous polyposis patients with APC gene mutations. Frontiers in Immunology, 14, 1163466.

 

Dhananjayan Venugopal | Environmental Toxicology | Best Researcher Award

Dr. Dhananjayan Venugopal | Environmental Toxicology | Best Researcher Award

Scientist, ICMR-Vector Control Research Centre (VCRC), Puducherry, India

Dr. V. Dhananjayan is a dedicated Scientist-C at the ICMR-Vector Control Research Centre (VCRC), Puducherry, specializing in vector biology and control. With over two decades of experience in environmental toxicology, he has significantly contributed to research on occupational health hazards and biomonitoring. His commitment to public health and environmental safety is evident in his extensive fieldwork, projects, and scholarly publications that address real-world toxicological concerns. ๐ŸŒฟ๐Ÿงช

Profile

Google Scholar

Education ๐ŸŽ“

Dr. Dhananjayan earned his Ph.D. in Environmental Science from Bharathiar University, Coimbatore in 2009, after completing dual M.Sc. degrees in Environmental Science (2001) and Chemistry. His technical skill set is enriched with diplomas in Industrial Pollution Control and Software Commercial Applications, showcasing a blend of scientific knowledge and applied technologies. ๐Ÿ“˜๐Ÿ”ฌ๐Ÿ’ป

Experience ๐Ÿ’ผ

With a progressive career starting as a Research Fellow at SACON (2001), Dr. Dhananjayan has worked across several ICMR institutes including NIOH and ROHCS, holding roles from Research Assistant to Technical Officer, and later Scientist-B and Scientist-C. His journey reflects a robust portfolio in occupational health, toxicology, and environmental monitoring, complemented by teaching and coordination roles. ๐Ÿง‘โ€๐Ÿซโš—๏ธ๐Ÿงฌ

Research Interest ๐Ÿ”

His core research interests lie in biomonitoring of pesticide exposure, toxicological assessments, DNA damage studies, and environmental health risks among vulnerable occupational groups. He has spearheaded and co-led numerous projects on PCBs, PAHs, heavy metals, and nanopesticide technology, striving to translate science into policy and prevention. ๐Ÿงซ๐ŸŒฑ๐Ÿ”

Awards ๐Ÿ†

Dr. Dhananjayan is a recipient of the DST-SERB Young Scientist Award under the Fast Track Scheme and the prestigious TICA Fellowship by the Thailand International Cooperation Agency. These honors recognize his contribution to environmental toxicology and his international collaborative research efforts. ๐ŸŽ–๏ธ๐ŸŒ๐Ÿ‡น๐Ÿ‡ญ

Publications ๐Ÿ“„

Risk assessment and contaminant characterization of PCBs, PAHs, and heavy metals โ€“ Marine Pollution Bulletin, In press ๐Ÿ”—Link

Nanopesticides for targeted pest and disease management โ€“ Agriculture Nanotech, In press ๐Ÿ”—Link

Personal Exposure to PAH and Inhalation Risk Assessment โ€“ Aerosol Sci. Eng., 2025 ๐Ÿ”—Link

Occupational injuries among tribal fishing communities โ€“ Journal of Agromedicine, 2024 ๐Ÿ”—Link

Environmental exposure to heavy metals in air โ€“ Spatial Modeling & Ecological Risk, 2024 ๐Ÿ”—Link

Assessment of Particulate and Gaseous Fluoride โ€“ Nature Env. & Pollution Tech., 2023 ๐Ÿ”—Link

Organochlorine pesticides in bird eggs โ€“ RSC Issues in Toxicology, 2023 ๐Ÿ”—Link

Geospatial variations in heavy metals and pesticides โ€“ Environ. Monit. Assess., 2023 ๐Ÿ”—Link

Urinary Fluoride Monitoring in Industrial Workers โ€“ Indian J. of Science & Technology, 2022 ๐Ÿ”—Link

Pesticide exposure in developing countries (collaborative paper) โ€“ Multiple international citations ๐Ÿ”—Link

Conclusion

Dr. V. Dhananjayan is an outstanding researcher with a strong background in environmental science and occupational health. His extensive research experience, impressive publication record, and leadership in research projects make him an ideal candidate for the Best Researcher Award. With some focus on interdisciplinary collaborations, international partnerships, and knowledge translation, Dr. Dhananjayan’s work could have an even greater impact.